The Board Meeting to be held on 30/05/2025 Stands Cancelled.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vanta Bioscience Limited has postponed its Board Meeting originally scheduled for May 30, 2025, which was meant to consider and approve the audited standalone and consolidated financial results for the half year and year ended March 31, 2025. The delay is because the company has not yet received the accounts of its Associate Company, making it impossible to prepare consolidated financial results within the SEBI-mandated deadline. The company will inform the stock exchanges of the revised meeting date in due course. The trading window for designated persons remains closed and will stay closed until 48 hours after the conclusion of the rescheduled board meeting.
This is a procedural delay rather than a fundamental issue, but it raises minor governance concerns as the company is missing the SEBI-prescribed filing deadline. Shareholders should watch for the revised meeting date and any potential qualifications in the forthcoming audited results once published.